Table 3.
Anticoagulants therapies at baseline.
| Therapy | Patients n (%) |
|---|---|
| Therapeutic anticoagulant | 10 (15.1) |
| Enoxaparin 100 UI/kg body weight bid | 7 (10.6) |
| Fondaparinux (based on body weight) | 1 (1.5) |
| Warfarin (based on INR) | 1 (1.5) |
| Rivaroxaban 20 mg | 1 (1.5) |
| Prophylactic anticoagulant | 55 (83.4) |
| Enoxaparin 4000 UI/die | 31 (47.0) |
| Enoxaparin 6000 UI/die | 4 (6.1) |
| Fondaparinux 2.5 mg | 18 (27.3) |
| Fondaparinux 1.5 mg (based on creatinine level) | 2 (3.0) |
| No anticoagulants | 1 (1.5) |